Plancorp LLC lowered its stake in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 9.4% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 35,344 shares of the company's stock after selling 3,671 shares during the quarter. Plancorp LLC's holdings in Procter & Gamble were worth $5,631,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also recently made changes to their positions in the stock. Motive Wealth Advisors lifted its holdings in shares of Procter & Gamble by 11.8% in the second quarter. Motive Wealth Advisors now owns 2,014 shares of the company's stock worth $321,000 after acquiring an additional 213 shares during the last quarter. Jeppson Wealth Management LLC raised its holdings in Procter & Gamble by 1.1% in the 2nd quarter. Jeppson Wealth Management LLC now owns 14,625 shares of the company's stock valued at $2,330,000 after buying an additional 155 shares during the last quarter. LeConte Wealth Management LLC raised its holdings in Procter & Gamble by 57.7% in the 2nd quarter. LeConte Wealth Management LLC now owns 2,221 shares of the company's stock valued at $354,000 after buying an additional 813 shares during the last quarter. Avaii Wealth Management LLC boosted its position in Procter & Gamble by 9.7% during the 2nd quarter. Avaii Wealth Management LLC now owns 2,121 shares of the company's stock worth $338,000 after buying an additional 188 shares during the period. Finally, McAdam LLC grew its holdings in Procter & Gamble by 15.0% during the 2nd quarter. McAdam LLC now owns 8,033 shares of the company's stock worth $1,280,000 after acquiring an additional 1,050 shares during the last quarter. Institutional investors own 65.77% of the company's stock.
Insider Activity
In other news, CEO Jennifer L. Davis sold 8,596 shares of the firm's stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $1,351,892.92. Following the completion of the sale, the chief executive officer directly owned 64,991 shares of the company's stock, valued at $10,221,134.57. This trade represents a 11.68% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Susan Street Whaley sold 1,000 shares of the firm's stock in a transaction on Friday, August 29th. The shares were sold at an average price of $156.84, for a total value of $156,840.00. Following the sale, the insider directly owned 28,436 shares of the company's stock, valued at approximately $4,459,902.24. This represents a 3.40% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 120,181 shares of company stock worth $18,918,012. 0.20% of the stock is owned by insiders.
Wall Street Analysts Forecast Growth
PG has been the subject of several recent research reports. Evercore ISI restated an "in-line" rating and issued a $170.00 price target (down from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. Berenberg Bank upped their price target on shares of Procter & Gamble from $152.00 to $154.00 and gave the company a "hold" rating in a research report on Wednesday, September 17th. JPMorgan Chase & Co. reissued a "neutral" rating and set a $170.00 target price (down previously from $178.00) on shares of Procter & Gamble in a research report on Friday, July 25th. BNP Paribas reaffirmed an "outperform" rating and set a $177.00 price objective on shares of Procter & Gamble in a research report on Friday, August 15th. Finally, Barclays set a $164.00 price objective on shares of Procter & Gamble and gave the stock an "equal weight" rating in a research report on Thursday, July 31st. One equities research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and eight have issued a Hold rating to the stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $173.94.
Check Out Our Latest Analysis on PG
Procter & Gamble Price Performance
Shares of PG opened at $152.35 on Thursday. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49. The business's fifty day moving average is $156.12 and its 200 day moving average is $160.91. Procter & Gamble Company has a 12-month low of $149.91 and a 12-month high of $180.43. The stock has a market cap of $356.58 billion, a P/E ratio of 23.40, a P/E/G ratio of 4.02 and a beta of 0.36.
Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, beating the consensus estimate of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The business had revenue of $20.89 billion for the quarter, compared to analysts' expectations of $20.79 billion. During the same period last year, the business earned $1.40 EPS. The business's revenue was up 1.7% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Sell-side analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 18th were given a dividend of $1.0568 per share. The ex-dividend date of this dividend was Friday, July 18th. This represents a $4.23 annualized dividend and a dividend yield of 2.8%. Procter & Gamble's dividend payout ratio (DPR) is currently 64.98%.
Procter & Gamble Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Articles
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report